Clinical Trial Update: Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tibulizumab for skin healing and inflammation in hidradenitis suppurativa is currently recruiting. No results are available ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Tibulizumab (Tibulizumab)

Snippet

Sponsor: Zura Bio Inc | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: RECRUITING